Advertisement
Research Article Free access | 10.1172/JCI119318
Department of Genetics, Stanford University, California 94305-5125, USA. roederer@darwin.stanford.edu
Find articles by Roederer, M. in: JCI | PubMed | Google Scholar
Department of Genetics, Stanford University, California 94305-5125, USA. roederer@darwin.stanford.edu
Find articles by Raju, P. in: JCI | PubMed | Google Scholar
Department of Genetics, Stanford University, California 94305-5125, USA. roederer@darwin.stanford.edu
Find articles by Mitra, D. in: JCI | PubMed | Google Scholar
Department of Genetics, Stanford University, California 94305-5125, USA. roederer@darwin.stanford.edu
Find articles by Herzenberg, L. in: JCI | PubMed | Google Scholar
Department of Genetics, Stanford University, California 94305-5125, USA. roederer@darwin.stanford.edu
Find articles by Herzenberg, L. in: JCI | PubMed | Google Scholar
Published April 1, 1997 - More info
In this report, we demonstrate that the T cell tropic strain of HIV, LAI, does not replicate in naive CD4 T cells stimulated by cross-linking CD3 and CD28. In contrast, LAI replicates well in memory CD4 T cells stimulated in the same way. Unlike this physiologically relevant stimulation, PHA stimulates productive LAI replication in both naive and memory T cells. These studies were conducted with highly purified (FACS-isolated) subsets of CD4 T cells identified by expression of both CD45RA and CD62L. Remixing of purified T cells showed that naive T cells do not suppress LAI replication in memory T cells and that memory T cells do not restore LAI expression in naive T cells. The suppression of productive LAI replication in naive T cells is not due to differential expression of viral coreceptors, nor is it due to inhibition of activation of the important HIV transcription factors, nuclear factor-kappaB and activator protein-1. The inherent resistance of naive T cells to productive HIV infection, coupled with their proliferative advantage as demonstrated here, provides a sound basis for proposed clinical therapies using ex vivo expansion and reinfusion of CD4 T cells from HIV-infected adults.